August 9, 2007 - Urologists and radiation oncologists expect the use of Image Guided Radiation Therapy (IGRT) to become much more widespread within the next few years, leading to more focused treatment that will be delivered in fewer sessions, according to a report released by market research group IMV Limited.
Despite the availability of many effective therapies, trade-offs between patient lifestyle factors and potential complications of treatment have led to controversy among urologists and radiation oncologists regarding the optimal mix of treatments for localized prostate cancer.
The report, Trends in the Prostate Cancer Treatment Market: 2007 and Beyond, which included 122 urologists and 115 radiation oncologists throughout the United States, indicated that urologists anticipate the use of laparoscopic radical prostatectomy will grow significantly in the near future, applying nerve-sparing techniques and using robotic assistance to assist in surgery as their first-line treatment of choice for patients with localized disease.
Other findings from the report include:
- over 90 percent of the urologists and all of the radiation oncologists in the survey have ordered or performed EBRT procedures for their patients with prostate cancer during the past twelve months.
- 78 percent of respondents have ordered or performed LDR brachytherapy seed implants for their patients with prostate cancer during the past twelve months.
For more information: www.imvinfo.com